EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Mesothelin Enhances Personalized Neoantigen Vaccine Induced Antitumor Immune Response in Orthotopic Pancreatic Cancer Mouse Models

Zhixiong Cai, Zhenli Li, Wenting Zhong, Fangzhou Lin, Xiuqing Dong, Honghao Ye, Yutong Guo, Geng Chen, Xiaoling Yu, Haijun Yu, Ruijing Tang, Xiaolong Liu iD

Advanced Science · 2025

DOI: 10.1002/advs.202407976 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Zhixiong Cai und 11 weiteren Autor:innen. Beteiligte Einrichtung: The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical Unive…. Hauptthemen laut MEDLINE: Mesothelin, Pancreatic Neoplasms, Cancer Vaccines, Antigens, Neoplasm. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Scientific Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immunosuppressive microenvironment in pancreatic cancer, characterized by low tumor‐specific T cells and excessive fibrosis, limits the effectiveness of immunotherapy. Here, three datasets and multi‐immunofluorescence staining of tissue microarrays in pancreatic cancer indicate that mesothelin (MSLN) expression negatively correlates with cytotoxic T cells in tumor. Anti‐MSLN antibody ( α MSLN) treatment of pancreatic cancer in vivo can significantly increase T cell infiltration. Meanwhile, the combination of α MSLN and neoantigen peptide vaccine identified from pancreatic cancer cell lines is demonstrated to be more effective in inducing neoantigen‐specific T cell generation and infiltration at subcutaneous and orthotopic pancreatic cancer models for enhancing antitumor efficacy. Single‐cell transcriptome analysis shows that the combined treatment significantly reduces the proportion of fibroblasts, improves the infiltration of IFN‐ γ + CD4 + and GZMK + CD8 + T cells, as well as reduces the interaction of antigen presentation‐associated ligands and receptors between antigen‐presenting Cancer‐Associated Fibroblasts (apCAFs) and naive CD4 + T cells. The negative correlations between apCAFs and CD8 + T cells/IFN‐ γ + CD4 + T cells are further confirmed in human pancreatic cancer tissues. Overall, this study demonstrates that targeting MSLN can improve neoantigen vaccine induced immune efficacy by reducing apCAFs to interrupt the conversion of naive CD4 + T cells to Tregs, and therefore increase the infiltration of tumor‐specific T cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MesothelinPancreatic NeoplasmsCancer VaccinesAntigens, NeoplasmAnimalsMiceHumansCell Line, TumorDisease Models, AnimalTumor MicroenvironmentImmunotherapyGPI-Linked Proteins

Stichwörter der Autor:innen

apCAFsimmunotherapymesothelinneoantigen vaccinepancreatic cancer

Substanzen

MesothelinCancer VaccinesAntigens, NeoplasmMsln protein, mouseMSLN protein, humanGPI-Linked Proteins

Autor:innen und Institutionen

  • The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China.
  • The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, P. R. China.
  • Mengchao Med-X Center, Fuzhou University, Fuzhou 350116, P. R. China.
  • State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P. R. China.

ORCID-Profile: Xiaolong Liu

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Scientific Foundation of Fujian Province
  • Fuzhou Science and technology planning project
  • Young and middle-aged talent research project of Fuzhou city
  • Major Research Projects for Young and Middle-aged Talent of Fujian Provincial Health Commission

Zitieren

APA

Cai, Z., Li, Z., Zhong, W., Lin, F., Dong, X., Ye, H., Guo, Y., Chen, G., Yu, X., Yu, H., Tang, R., & Liu, X. (2025). Targeting Mesothelin Enhances Personalized Neoantigen Vaccine Induced Antitumor Immune Response in Orthotopic Pancreatic Cancer Mouse Models. Advanced Science. https://doi.org/10.1002/advs.202407976

Vancouver

Cai Z, Li Z, Zhong W, Lin F, Dong X, Ye H, et al. Targeting Mesothelin Enhances Personalized Neoantigen Vaccine Induced Antitumor Immune Response in Orthotopic Pancreatic Cancer Mouse Models. Advanced Science. 2025. doi:10.1002/advs.202407976

BibTeX
@article{Cai2025,
  author = {Cai, Zhixiong and Li, Zhenli and Zhong, Wenting and Lin, Fangzhou and Dong, Xiuqing and Ye, Honghao and Guo, Yutong and Chen, Geng and Yu, Xiaoling and Yu, Haijun and Tang, Ruijing and Liu, Xiaolong},
  title = {Targeting Mesothelin Enhances Personalized Neoantigen Vaccine Induced Antitumor Immune Response in Orthotopic Pancreatic Cancer Mouse Models},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202407976}
}
Kostenlos starten →